Corporate ActionMay 14, 2026, 09:12 AM
XORTX Announces US$5 Million Public Offering
AI Summary
XORTX Therapeutics Inc. announced the pricing of a public offering to raise US$5 million in gross proceeds. The offering consists of 2,659,574 common shares or common share equivalents in the form of pre-funded warrants, priced at US$1.88 per share or warrant. The pre-funded warrants are immediately exercisable with a nominal exercise price of US$0.0001 per share. The offering is anticipated to close around May 15, 2026, pending customary closing conditions and regulatory approvals.
Key Highlights
- XORTX announced a public offering to raise US$5 million in gross proceeds.
- The offering includes 2,659,574 common shares or pre-funded warrants.
- Shares and pre-funded warrants are priced at US$1.88 each.
- Pre-funded warrants have an exercise price of US$0.0001 per share.
- The offering is expected to close on or about May 15, 2026.
- E.F. Hutton & Co. is acting as the exclusive placement agent.
Price Impact
More from XRTX